0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

Original Investigation | 
Markus Juonala, MD, PhD; Laura Pulkki-Råback, PhD; Marko Elovainio, PhD; et al.
JAMA Pediatr. 2016;170(5):466-472. doi:10.1001/jamapediatrics.2015.4121.

Sign in

Purchase Options

• Subscribe to the journal
• Rent this article ?

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
From The JAMA Network
JAMA
Original Investigation  | 
Development and Validation of a Protein-Based Risk Score for Cardiovascular Outcomes Among Patients With Stable Coronary Heart Disease
Peter Ganz, MD; Bettina Heidecker, MD; Kristian Hveem, MD, PhD; et al.
JAMA
Viewpoint  | 
Low-Dose Aspirin in the Primary Prevention of Cardiovascular Disease Shared Decision Making in Clinical Practice
Samia Mora, MD, MHS; Jeffrey M. Ames, BS, MEng; JoAnn E. Manson, MD, DrPH
JAMA Cardiology
Original Investigation  | 
Long-term Tolerability of Ticagrelor for the Secondary Prevention of Major Adverse Cardiovascular Events A Secondary Analysis of the PEGASUS-TIMI 54 Trial
Marc P. Bonaca, MD, MPH; Deepak L. Bhatt, MD, MPH; Ton Oude Ophuis, MD; et al.
JAMA Cardiology
Editorial  | 
Understanding the Adverse Effects of Ticagrelor in Practice
Christopher B. Granger, MD; Peter B. Berger, MD